Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-10070%EBIT Margin
VS
Market
Sector
Industry
History
$ 2.02Close
$ 1.52 - $ 4.62 52-Week Range
Ticker Information
Ticker
MREOCompany Name
MEREO BIOPHARMA GROUP PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQMEREO BIOPHARMA GROUP PLC - EBIT Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
MREO - EBIT % Historical data
| Date | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -50.35M | -10070% | $ 500K |
| 3/31/2025 | $ -47.31M | 0% | $ 0 |
| 12/31/2024 | $ -43.53M | 0% | $ 0 |
| 6/30/2024 | $ -36.76M | -3372.68% | $ 1.09M |
| 12/31/2023 | $ -28.4M | -283.97% | $ 10M |
| 6/30/2023 | $ -31.42M | -352.65% | $ 8.91M |
| 12/31/2022 | $ -40.91M | 0% | $ 0 |
| 6/30/2022 | $ -15.83M | 0% | $ 0 |
| 12/31/2021 | $ 22.83M | 50.09% | $ 45.58M |
| 6/30/2021 | $ -148.38M | -325.53% | $ 45.58M |
Key Performance Insights, Last 5 Years
- MEREO BIOPHARMA GROUP PLC's latest trailing twelve months (TTM) EBIT % stands at 0%.
- Over the past 5 years, MEREO BIOPHARMA GROUP PLC's average EBIT % has been -2392.46%.
- The median EBIT % for MEREO BIOPHARMA GROUP PLC during this period was -339.09%
- MEREO BIOPHARMA GROUP PLC reached its highest EBIT % over the past 5 years at 50.09%.
- The lowest EBIT % recorded by MEREO BIOPHARMA GROUP PLC in the same timeframe -10070%
MEREO BIOPHARMA GROUP PLC's EBIT % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT % Benchmarks
Similar metrics to Revenues:
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Operating Margin - [Calculation] A company’s operating income [OpInc] as a percentage of [Revenue]. The operating margin measures how much profit a company produces for each dollar of revenue generated, after paying for variable costs such as wages and raw materials.
Definition of EBIT Margin
[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.EBIT / Revenues
(=) EBIT % EBIT % for MEREO BIOPHARMA GROUP PLC is calculated as follows: EBIT [ $ -200.08M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ] MREO - EBIT Margin, Last 5 years
-10070%
Minimum
Jun 30, 2025
50.09%
Maximum
Dec 31, 2021
-2392.46%
Average
-339.09%
Median
EBIT % Benchmark AnalysisMarket
The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
| filtered constituents | 3.26K |
|---|---|
| min | -73.16% |
| max | 83.08% |
| average | 9.54% |
| median | 9.01% |
| std | 23.96% |